Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Pelthos Therapeutics Inc. (PTHS) vs Telomir Pharmaceuticals, Inc. (TELO)

Pelthos Therapeutics Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Pelthos Therapeutics Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($85.8M and $83.2M). Telomir Pharmaceuticals, Inc. has the higher net margin (0.00% vs −199.5%) and the higher return on invested capital (0.00% vs −82.3%). Across the 12 metrics below, Telomir Pharmaceuticals, Inc. leads on 8 and Pelthos Therapeutics Inc. on 4.

Valuation

Metric PTHS TELO Biotechnology median
P/E n/m n/m 7.88
P/S 1.82 n/m 11.47
P/B n/m 14.75 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.92 n/m 10.73
Earnings yield (128.97%) (74.59%) (28.84%)
Free cash flow yield (54.04%) (6.62%) (23.03%)

Profitability

Metric PTHS TELO Biotechnology median
Gross margin 78.59% — 65.16%
Operating margin (133.42%) 0.00% 0.00%
Net margin (199.50%) 0.00% 0.00%
Free cash flow margin (98.37%) 0.00% 0.00%
Return on equity 2,161.07% (1,885.50%) (57.72%)
Return on assets (125.04%) (1,678.31%) (49.22%)
Return on invested capital (82.34%) 0.00% 0.00%

Growth

Metric PTHS TELO Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (61.12%) 41.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric PTHS TELO Biotechnology median
Debt to equity (46.58) 0.03 0.00
Current ratio 1.98 16.14 4.73
Net debt to EBITDA (0.45) 0.69 0.96

Dividend

Metric PTHS TELO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric PTHS TELO Biotechnology median
Market cap 85.76m 83.22m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack